Emkay Global anticipates that Dabur will benefit from consumption recovery, leveraging its stable distribution expansion, extensive portfolio category coverage, continued emphasis on innovation, and sufficient liquidity for bolt-on acquisitions.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale